Persistent illness prevention and administration platform Lark Well being introduced it will likely be obtainable by way of CVS Caremark’s Level Options Administration program.
CVS Caremark prospects could have the flexibility to entry Lark’s teaching applications, together with the corporate’s GLP-1 value containment and weight problems administration choices, by way of CVS Caremark’s platform.
In a LinkedIn submit, Lark stated it can tailor a holistic program that’s scalable, obtainable 24/7 and constructed upon particular employer wants, together with medical value financial savings, habits change-driven weight reduction options for applicable members and predictive modeling to extend insights into customized GLP-1 administration and commencement.
Lark Well being presents applications to assist forestall and handle hypertension and diabetes. The Lark app can be utilized with linked units, comparable to scales, blood strain displays and blood glucose displays. The app will also be used to speak with Lark coaches.
“Employers are responding to great demand for GLP-1 drugs and weight administration amongst workers and given the prices of those medication, they want versatile options that match their members’ wants,” Julia Hu, Lark Well being CEO and cofounder, stated on LinkedIn.
THE LARGER TREND
In 2024, Lark Well being appointed Darren Eckberg as chief progress officer to supervise the enlargement of the corporate’s AI-enabled GLP-1 cost-containment know-how.
Eckberg beforehand held govt positions at EnvisionRx/Ceremony Support, Specific Scripts, Prime Therapeutics and IngenioRx/Anthem.
In 2022, Lark Well being developed an AI-enabled platform geared toward stopping and managing atherosclerotic heart problems and coronary artery illness in partnership with Roche Diagnostics.
In 2021, Lark Well being secured $100 million in a Collection D funding spherical. Deerfield Administration Firm led the elevate, with participation from PFM Well being Sciences and returning buyers Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital and Marvell Expertise cofounder Weili Dai.
